University of Chicago Medicine adopts CTVQ
Filed with ASX · · 2 pages · English
Summary by 6ix AI
4DMedical Ltd. announces that the University of Chicago Medicine has adopted its CT:VQ™ technology for commercial deployment, expanding their existing partnership. This agreement marks UChicago Medicine as the fifth U.S. academic medical center to implement CT:VQ™, following other prestigious institutions. The partnership includes a renewed imaging analysis platform agreement and a commercial contract with an initial package of prepaid scans to facilitate clinical deployment. 4DMedical's CEO highlighted the significance of this expansion as validation of the clinical value of their technology and their commercialization strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- Quarterly Activity Report and Appendix 4C
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
- 4DMedical completes $150 million institutional placement
- Trading Halt
- UC San Diego Health adopts CTVQ
Later from 4DMedical
- Response to ASX Query Letter
- Appendix 4D and FY26 Half Year Report
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- CTVQ deployed at Mayo Clinic
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical